Our rich history of discovery and innovation began 125 years ago and continues today.
Through the years, our researchers have helped to find new ways to treat and prevent illness in people and animals around the world. We’ve done great things in the past. Today, we’re doing great things for the future.
Our company is an innovative, global health care leader that is committed to improving health and well-being around the world.
Our company has more than 50 prescription products in key therapeutic areas such as cardiovascular disease, respiratory disease, oncology, neuroscience, infectious disease, immunology and women’s health.
Our core product categories include diabetes, cancer, vaccines and hospital acute care. We continue to focus our research on conditions that represent some of today’s most significant health challenges—like cancer, hepatitis C, cardio-metabolic disease, antibiotic-resistant infection and Alzheimer’s disease, and we are on the front lines in the fight against emerging global pandemics, such as ebola.
We also devote extensive time and energy to increasing access to medicines and vaccines through far-reaching programs that donate and deliver our products to the people who need them.
We’re applying our global reach, financial strength and scientific excellence to do more of what we’re passionate about: improving health and improving lives.
Prescription Products and Prescribing Information
Our core business is the discovery and development of prescription medicines for diseases and conditions that impact millions of people.
We invest billions of research dollars to find medicines that can help improve lives. Today, our company has more than 50 prescription products in key therapeutic areas such as cardiovascular disease, respiratory disease, oncology, neuroscience, infectious disease, immunology and women’s health.
To learn more, click here.
Vaccines are one of the greatest public health success stories in history, and our company has played its part in that story.
We are dedicated to the complex business of researching and producing vaccines. Our unique vaccines have helped prevent a number of diseases, including ones never thought preventable. To learn more, click here.
Through our company’s animal health business, we are a global leader in the research, development, manufacturing and sale of veterinary medicines.
We offer a broad choice of vaccines, anti-infective and antiparasitic drugs, a complete range of fertility management products, pharmaceutical specialty products, innovative delivery solutions, performance technologies, and value-added programs, such as pet recovery services and livestock data management tools. Learn more about our Animal Health business.*
With a steady focus on innovation and sound science, we work to deliver vaccines, medications, and consumer and animal health products that can help millions around the world. View a list of products marketed in the U.S.
Our pipeline provides an overview of our late-stage clinical development programs and is updated quarterly. Explore our pipeline.
Kenneth C. Frazier, chairman of the board, president and chief executive officer
Robert M. Davis, executive vice president and chief financial officer
View the list of Executive Committee members.
The company, Merck & Co., Inc., Kenilworth, N.J., USA, is known as MSD outside the United States and Canada and is listed on the New York Stock Exchange under the symbol “MRK.”
|* The website listed above may refer to products that either are not available in your country or are marketed under a different trade name. In addition, the safety and efficacy data and the withholding periods for a specific product may be different depending on local regulations. Please consult your veterinarian for more information.|